Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss)

v2.4.0.8
Condensed Consolidated Statements of Operations and Comprehensive Income/(Loss) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenues:    
Product Revenue $ 324,207 $ 382,148
Product Revenue - Related party 766,379 919,822
License Revenue 0 200,000
License Revenue - Related party 83,333 83,333
Total Revenue 1,173,919 1,585,303
Cost of Sales:    
Product Cost of Sales (604,323) (776,245)
Gross Profit 569,596 809,058
Administrative Expenses 458,680 210,927
Administrative Expenses - Related parties 195,002 83,751
Sales and Marketing Expenses 211,098 233,906
Research and Development Expenses 253,538 247,716
Amortization of Non-Current Assets 64,643 64,643
Loss from Operations (613,365) (31,885)
Other (Income)/Expenses    
Foreign Currency Transaction (Income)/Expense (2,399) 87
Gain from demutualization of insurance carrier (4,669) (91,286)
Interest and Dividend Income (10,697) (1,054)
Total Other Income (17,765) (92,253)
Income/(Loss) Before Income Taxes (595,600) 60,368
Income Tax Benefit 0 0
Net Income/(Loss) (595,600) 60,368
Other Comprehensive Loss    
Unrealized Losses on Marketable Securities (10,874) 0
Total Other Comprehensive Loss (10,874) 0
Comprehensive Income/(Loss) $ (606,474) $ 60,368
Basic & diluted earnings/(loss) per common share $ (0.14) $ 0.05
Weighted average basic & diluted common shares outstanding 4,197,937 1,278,948